BLOG

endpoints

The renowned drug hunter, the Washington insider, the MIT strategist: How did one low-profile biotech enlist a dream team of top biotech advisors?

When you’re heading up a fledgling biotech out to make a name for yourself in the middle of a wild industry boom, there’s one sure way to differentiate yourself that’s bound to attract universal nods.